References
Lee KS. Ibutilide, a new compound with potent class III antiarrhythmic activity, activates a slow inward Na+ current in guinea pig ventricular cells. J Pharmacol Exp Ther 1992;262:99-108.
Yang T, Snyders DJ, Roden DM. Ibutilide, a methanesulfonanilide antiarrhythmic, is a potent blocker of the rapidly-activating delayed rectifier K+ current (IKr) in AT-1 cells. Circulation 1995;91:1799-1806.
Lynch JJ, Baskin EP, Nutt EM, et al. Comparison of binding to rapidly activating delayed rectifier K+ channel, Ikr, and effects on myocardial refractoriness for class III antiarrhythmic agents. J Cardiovasc Pharmacol 1995;25:336- 340.
Cimini MG, Brunden MN, Gibson JK. Effects of ibutilide fumarate, a novel antiarrhythmic agent, and its enantiomers on isolated rabbit myocardium. Eur J Pharmacol 1992; 222:93-98.
Buchanan LV, LeMay RJ, Walters RR, et al. Antiarrhythmic and electrophysiologic effects of intravenous ibutilide and sotalol in the canine sterile pericarditis model. J Cardiovasc Electrophysiol 1996;7:113-119.
Stambler BS, Wood MA, Ellenbogen KA. Antiarrhythmic actions of intravenous ibutilide compared with procainamide during human atrial flutter and fibrillation. Electrophysiological determinants of enhanced conversion efficacy. Circulation 1997;96:4298-4306.
Buchanan LV, Lemay RJ, Gibson JK. Comparison of the antiarrhythmic agents d,l-sotalol HCl and ibutilide fumarate for atrial reverse use dependence and antiarrhythmic effects. PACE 1996;19:687. (Abstract).
Stambler BS, Beckman KJ, Kadish AH, et al. Acute hemodynamic effects of intravenous ibutilide in patients with or without reduced left ventricular function. Am J Cardiol 1997;80:458-463.
Ellenbogen KA, Stambler BS, Wood MA, et al. Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: a dose response study. J Am Coll Cardiol 1996;28:130-136.
Stambler BS, Wood MA, Ellenbogen K, et al. Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. 1996; 94:1613-1621.
Mattioni T, Denker S, Riggio D, et al. Efficacy and safety of intravenous ibutilide in the treatment of atrial flutter and atrial fibrillation following valvular or coronary artery bypass surgery. PACE 1997;20:1059. (Abstract).
Volgman AS, Carberry PA, Stambler BS, et al. Conversion efficacy and safety of intravenous ibutilide compared with intravenous procainamide in patients with atrial flutter or fibrillation. J Am Coll Cardiol 1998;31:1414-1419.
Stambler BS, Wood MA, Ellenbogen KA. Comparative efficacy of intravenous ibutilide versus procainamide for enhancing termination of atrial flutter by atrial overdrive pacing. Am J Cardiol 1996;77:960-966.
Wesley RC, Farkhani F, Morgan D, Zimmerman D. Ibutilide: enhanced defibrillation via plateau sodium current activation. Am J Physiol 1993;264:H1269-H1274.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Stambler, B.S. Ibutilide. Card Electrophysiol Rev 2, 173–175 (1998). https://doi.org/10.1023/A:1009967713885
Issue Date:
DOI: https://doi.org/10.1023/A:1009967713885